s 14671 has been researched along with flibanserin in 1 studies
| Studies (s 14671) | Trials (s 14671) | Recent Studies (post-2010) (s 14671) | Studies (flibanserin) | Trials (flibanserin) | Recent Studies (post-2010) (flibanserin) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 168 | 14 | 123 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bietti, G; Borsini, F; Ceci, A; Donetti, A | 1 |
1 other study(ies) available for s 14671 and flibanserin
| Article | Year |
|---|---|
BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Benzimidazoles; Binding, Competitive; Buspirone; Cerebral Cortex; Dose-Response Relationship, Drug; In Vitro Techniques; Iontophoresis; Male; Microelectrodes; Neurons; Piperazines; Prazosin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 1995 |